The Company expects that the reverse stock split, which was approved by the Company's stockholders on November 27, 2024, will increase the price per share of the Company's common stock, and is part of ...
AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...
Janover Inc. (Nasdaq: JNVR) ("Janover" or the "Company"), an AI-enabled platform connecting the commercial real estate industry, today announced that ...